Jill Bechtel

1.1k total citations
11 papers, 869 citations indexed

About

Jill Bechtel is a scholar working on Epidemiology, Oncology and Hepatology. According to data from OpenAlex, Jill Bechtel has authored 11 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 4 papers in Oncology and 4 papers in Hepatology. Recurrent topics in Jill Bechtel's work include Cytomegalovirus and herpesvirus research (6 papers), Viral-associated cancers and disorders (4 papers) and Hepatitis C virus research (4 papers). Jill Bechtel is often cited by papers focused on Cytomegalovirus and herpesvirus research (6 papers), Viral-associated cancers and disorders (4 papers) and Hepatitis C virus research (4 papers). Jill Bechtel collaborates with scholars based in United States, United Kingdom and Australia. Jill Bechtel's co-authors include Don Ganem, Thomas Shenk, Robert F. Kalejta, Yuying Liang, Richard C. Winant, Michael Lagunoff, Martin McMahon, Nancy W. Abbey, Brian Herndier and Eleni Venetsanakos and has published in prestigious journals such as Molecular and Cellular Biology, Journal of Virology and Journal of Hepatology.

In The Last Decade

Jill Bechtel

11 papers receiving 855 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jill Bechtel United States 8 684 510 149 132 106 11 869
Barbora Lubyová Czechia 14 427 0.6× 541 1.1× 137 0.9× 252 1.9× 607 5.7× 22 1.1k
M G Davis United States 10 442 0.6× 150 0.3× 109 0.7× 141 1.1× 110 1.0× 12 655
David N. Everly United States 14 482 0.7× 364 0.7× 82 0.6× 388 2.9× 335 3.2× 18 1.0k
Satoko Iwahori Japan 21 458 0.7× 442 0.9× 113 0.8× 366 2.8× 134 1.3× 31 922
Sanae Nakayama Japan 17 430 0.6× 392 0.8× 66 0.4× 285 2.2× 145 1.4× 22 775
Maria M. Medveczky United States 17 746 1.1× 766 1.5× 138 0.9× 103 0.8× 213 2.0× 31 1.1k
Huaxin Si United States 12 348 0.5× 356 0.7× 64 0.4× 113 0.9× 87 0.8× 17 595
Noriko Shirata Japan 14 418 0.6× 418 0.8× 62 0.4× 367 2.8× 118 1.1× 16 821
J S Pagano Germany 13 383 0.6× 458 0.9× 216 1.4× 84 0.6× 112 1.1× 21 720
Hong-Guang Guo United States 8 297 0.4× 369 0.7× 99 0.7× 125 0.9× 277 2.6× 10 745

Countries citing papers authored by Jill Bechtel

Since Specialization
Citations

This map shows the geographic impact of Jill Bechtel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill Bechtel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill Bechtel more than expected).

Fields of papers citing papers by Jill Bechtel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill Bechtel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill Bechtel. The network helps show where Jill Bechtel may publish in the future.

Co-authorship network of co-authors of Jill Bechtel

This figure shows the co-authorship network connecting the top 25 collaborators of Jill Bechtel. A scholar is included among the top collaborators of Jill Bechtel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill Bechtel. Jill Bechtel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Voitenleitner, Christian, Jill Bechtel, Ann Arfsten, & Robert Hamatake. (2012). Hepatitis C Genotype 1a Replicon Improved Through Introduction of Fitness Mutations. BioTechniques. 52(4). 273–275. 4 indexed citations
2.
Bechtel, Jill, et al.. (2011). Targeting the NS5A protein of HCV: An emerging option. Drugs of the Future. 36(9). 691–691. 32 indexed citations
3.
Bechtel, Jill, Renae M. Crosby, Stephanie Van Horn, et al.. (2011). 764 IN VITRO PROFILING OF GSK2336805, A POTENT AND SELECTIVE INHIBITOR OF HCV NS5A. Journal of Hepatology. 54. S307–S308. 7 indexed citations
4.
Voitenleitner, Christian, Renae M. Crosby, Jill Bechtel, et al.. (2011). 818 PRECLINICAL CHARACTERIZATION OF GSK2485852, A NOVEL HCV POLYMERASE INHIBITOR. Journal of Hepatology. 54. S328–S328. 1 indexed citations
5.
Bryson, Paul D., Nam‐Joon Cho, Shirit Einav, et al.. (2010). A small molecule inhibits HCV replication and alters NS4B's subcellular distribution. Antiviral Research. 87(1). 1–8. 32 indexed citations
6.
Bechtel, Jill, Richard C. Winant, & Don Ganem. (2005). Host and Viral Proteins in the Virion of Kaposi's Sarcoma-Associated Herpesvirus. Journal of Virology. 79(8). 4952–4964. 145 indexed citations
7.
Bechtel, Jill, Adam Grundhoff, & Don Ganem. (2005). RNAs in the Virion of Kaposi's Sarcoma-Associated Herpesvirus. Journal of Virology. 79(16). 10138–10146. 62 indexed citations
8.
Kalejta, Robert F., Jill Bechtel, & Thomas Shenk. (2003). Human Cytomegalovirus pp71 Stimulates Cell Cycle Progression by Inducing the Proteasome-Dependent Degradation of the Retinoblastoma Family of Tumor Suppressors. Molecular and Cellular Biology. 23(6). 1885–1895. 159 indexed citations
9.
Bechtel, Jill, et al.. (2003). Host Range of Kaposi's Sarcoma-Associated Herpesvirus in Cultured Cells. Journal of Virology. 77(11). 6474–6481. 197 indexed citations
10.
Lagunoff, Michael, Jill Bechtel, Eleni Venetsanakos, et al.. (2002). De Novo Infection and Serial Transmission of Kaposi's Sarcoma-Associated Herpesvirus in Cultured Endothelial Cells. Journal of Virology. 76(5). 2440–2448. 164 indexed citations
11.
Bechtel, Jill & Thomas Shenk. (2002). Human Cytomegalovirus UL47 Tegument Protein Functions after Entry and before Immediate-Early Gene Expression. Journal of Virology. 76(3). 1043–1050. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026